These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36930561)

  • 41. Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer.
    Bogdanos DP; Gkoutzourelas A; Papadopoulos V; Liaskos C; Patrikiou E; Tsigalou C; Saratziotis A; Hajiioannou J; Scheper T; Meyer W; Sakkas LI; Papandreou C
    Clin Chim Acta; 2021 Oct; 521():199-205. PubMed ID: 34245687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease.
    Jones EL; Laidlaw SM; Dustin LB
    Front Immunol; 2021; 12():738473. PubMed ID: 34552597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases.
    Chalayer E; Gramont B; Zekre F; Goguyer-Deschaumes R; Waeckel L; Grange L; Paul S; Chung AW; Killian M
    Autoimmun Rev; 2022 Mar; 21(3):103016. PubMed ID: 34915182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death.
    Espinosa A; Zhou W; Ek M; Hedlund M; Brauner S; Popovic K; Horvath L; Wallerskog T; Oukka M; Nyberg F; Kuchroo VK; Wahren-Herlenius M
    J Immunol; 2006 May; 176(10):6277-85. PubMed ID: 16670339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases.
    Simon Q; Grasseau A; Boudigou M; Le Pottier L; Bettachioli E; Cornec D; Rouvière B; Jamin C; Le Lann L; ; ; Borghi MO; Aguilar-Quesada R; Renaudineau Y; Alarcón-Riquelme ME; Pers JO; Hillion S
    Arthritis Rheumatol; 2021 Aug; 73(8):1550-1561. PubMed ID: 33605069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
    Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases.
    Peker BO; Şener AG; Tarhan EF; Kaya S
    Clin Rheumatol; 2019 Dec; 38(12):3627-3633. PubMed ID: 31396837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
    Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
    Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
    Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
    Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
    Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.
    Arase N; Tsuji H; Takamatsu H; Jin H; Konaka H; Hamaguchi Y; Tonomura K; Kotobuki Y; Ueda-Hayakawa I; Matsuoka S; Hirano T; Yorifuji H; Murota H; Ohmura K; Nakashima R; Sato T; Kumanogoh A; Katayama I; Arase H; Fujimoto M
    J Autoimmun; 2022 Jan; 126():102774. PubMed ID: 34896887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic utility of anti-Ro52 detection in systemic autoimmunity.
    Dugar M; Cox S; Limaye V; Gordon TP; Roberts-Thomson PJ
    Postgrad Med J; 2010 Feb; 86(1012):79-82. PubMed ID: 20145055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
    Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
    Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?
    Umare V; Nadkarni A; Nadkar M; Rajadhyksha A; Khadilkar P; Ghosh K; Pradhan VD
    J Postgrad Med; 2017; 63(2):92-95. PubMed ID: 27531690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Significance of Different Profiles of anti-Ro Antibodies in Connective Tissue Diseases.
    Yang HT; Hong XP; Guo JW; Zhong XL; Liao R; Liu CL; Liu LX; Li K; Chen YL; Liu DZ
    J Immunol Res; 2023; 2023():9195157. PubMed ID: 36741231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases.
    Lee AYS; Reed JH; Gordon TP
    J Autoimmun; 2021 Nov; 124():102724. PubMed ID: 34464814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
    Gál I; Lakos G; Zeher M
    Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
    Seelig CA; Bauer O; Seelig HP
    Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patients.
    Massie C; Hudson M; Tatibouet S; Steele R; Huynh T; Fritzler MJ; Baron M; Pineau CA;
    Semin Arthritis Rheum; 2014 Dec; 44(3):338-44. PubMed ID: 25128430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.